VEGF, an angiogenic cytokine, binds VEGFR-2 on endothelial cells, activating PI3K/Akt and Raf/MEK/ERK pathways, thereby promoting endothelial migration, and MM cell survival and proliferation [112]. Here, MAP2K7 is linked to Miyoshi myopathy.